ALS is a debilitating and ultimately fatal neurological disorder for which there is currently no cure.
Targeting pathogenic mechanisms involved in ALS disease progression may lead to neuroprotection and an effective treatment.
This review draws attention to recent developments for the treatment of ALS in the SOD1 transgenic mouse model.